Skip to main content

Carbetapentane / guaifenesin / pseudoephedrine Pregnancy and Breastfeeding Warnings

Brand names: Exall-D

Carbetapentane / guaifenesin / pseudoephedrine Pregnancy Warnings

Carbetapentane/guaifenesin/pseudoephedrine has been assigned to FDA pregnancy category C. Animal studies have not been reported. There are no controlled data in human pregnancy. The manufacturer recommends that carbetapentane/guaifenesin/pseudoephedrine not be administered to pregnant women.

See references

Carbetapentane / guaifenesin / pseudoephedrine Breastfeeding Warnings

There are no data on the excretion of carbetapentane/guaifenesin/pseudoephedrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

Does Carbetapentane/guaifenesin/pseudoephedrine interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

References for pregnancy information

  1. (2009) "Product Information. Exall-D (carbetapentane/guaifenesin/pseudoephedrine)." Hawthorn Pharmaceuticals

References for breastfeeding information

  1. (2009) "Product Information. Exall-D (carbetapentane/guaifenesin/pseudoephedrine)." Hawthorn Pharmaceuticals

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer